This biotech stock is on TD Cowen's best smidcap ideas list
TD Cowen has named a rare disease drugmaker one of its top small- and mid-cap (smidcap) picks for 2026, arguing ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
